U.S. market Closed. Opens in 3 hours 1 minute

ARDS | Aridis Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/A1.00M1.02M2.76M860.00K2.27M
Cost of RevenueN/AN/AN/AN/AN/AN/A1.93M
Gross ProfitN/AN/A1.00M1.02M2.76M860.00K342.00K
Operating Expenses29.99M43.71M23.40M30.11M26.87M20.60M8.23M
Selling, General & Admin7.16M7.31M6.45M6.03M3.87M3.16M1.97M
Research & Development25.92M37.94M16.96M24.08M23.00M17.44M6.26M
Other Operating Expenses-3.09M-1.53MN/AN/AN/AN/AN/A
Operating Income-29.99M-43.71M-22.40M-29.09M-24.12M-19.74M-7.88M
Other Expenses / Income-378.00K518.00K68.00K-594.00K1.59M-4.92M-538.00K
Before Tax Income-30.37M-43.19M-22.33M-29.68M-22.11M-24.66M-8.42M
Income Tax Expenses378.00K-912.00K-414.00K-695.00K2.43MN/AN/A
Net Income-30.75M-42.28M-21.92M-28.99M-22.11M-24.66M-8.42M
Interest Expenses378.00K-245.00KN/AN/A420.00KN/A366.00K
Basic Shares Outstanding18.78M12.29M9.17M8.46M3.15M7.89M7.89M
Diluted Shares Outstanding18.78M12.29M9.17M8.46M3.15M7.89M7.89M
EBITDA-29.51M-44.43M-22.40M-29.09M-25.75M-24.59M-8.03M
EBITDA Margin0.00%0.00%-2,240.10%-2,846.09%-933.95%-2,859.77%-354.03%
EBIT-29.99M-43.44M-22.33M-29.68M-19.25M-24.66M-8.06M
EBIT Margin0.00%0.00%-2,233.30%-2,904.21%-698.33%-2,866.98%-355.05%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙